Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Paul, Browne"'
Autor:
Lorena Escudero Sanchez, Thomas Buddenkotte, Mohammad Al Sa’d, Cathal McCague, James Darcy, Leonardo Rundo, Alex Samoshkin, Martin J. Graves, Victoria Hollamby, Paul Browne, Mireia Crispin-Ortuzar, Ramona Woitek, Evis Sala, Carola-Bibiane Schönlieb, Simon J. Doran, Ozan Öktem
Publikováno v:
Diagnostics, Vol 13, Iss 17, p 2813 (2023)
Artificial intelligence (AI) methods applied to healthcare problems have shown enormous potential to alleviate the burden of health services worldwide and to improve the accuracy and reproducibility of predictions. In particular, developments in comp
Externí odkaz:
https://doaj.org/article/23f83dcec95a4760b00c763e618e66f3
Autor:
Liam Townsend, Adam H. Dyer, Aifric Naughton, Sultan Imangaliyev, Jean Dunne, Rachel Kiersey, Dean Holden, Aoife Mooney, Deirdre Leavy, Katie Ridge, Jamie Sugrue, Mubarak Aldoseri, Jo Hannah Kelliher, Martina Hennessy, Declan Byrne, Paul Browne, Christopher L. Bacon, Catriona Doyle, Ruth O’Riordan, Anne-Marie McLaughlin, Ciaran Bannan, Ignacio Martin-Loeches, Arthur White, Rachel M. McLoughlin, Colm Bergin, Nollaig M. Bourke, Cliona O’Farrelly, Niall Conlon, Clíona Ní Cheallaigh
Publikováno v:
Heliyon, Vol 8, Iss 4, Pp e09230- (2022)
SARS-CoV-2 infection causes a wide spectrum of disease severity. Identifying the immunological characteristics of severe disease and the risk factors for their development are important in the management of COVID-19. This study aimed to identify and
Externí odkaz:
https://doaj.org/article/2042931142d64da28927de464f03535e
Autor:
Laurent Garderet, Meral Beksac, Cecilia Isaksson, Stig Lenhoff, Xavier Poiré, Alina Tanase, Giulia Sbianchi, Soledad González Muñiz, Jenny Byrne, Jane F. Apperley, Paul Browne, Linda Koster, Simona Iacobelli, Arnon Nagler, Ibrahim Yakoub-Agha, Jiri Mayer, Cyrille Touzeau, Marek Trneny, Rocio Parody Porras, Grzegorz W. Basak, Patrick Hayden, Didier Blaise, Mariagrazia Michieli, Péter Reményi, Stefan Schönland
Publikováno v:
European journal of haematology, Vol. 106, no.5, p. 708-715 (2021)
Background In autologous stem cell transplant (ASCT)-eligible myeloma patients, prolonged induction does not necessarily improve the depth of response. Method We analysed 1,222 ASCT patients who were classified based on (1) the interval between induc
Autor:
Sebastian Giebel, Myriam Labopin, Gerard Socié, Dietrich Beelen, Paul Browne, Liisa Volin, Slawomira Kyrcz-Krzemien, Ibrahim Yakoub-Agha, Mahmoud Aljurf, Depei Wu, Mauricette Michallet, Renate Arnold, Mohamad Mohty, Arnon Nagler
Publikováno v:
Haematologica, Vol 102, Iss 1 (2017)
Allogeneic hematopoietic cell transplantation is widely used to treat adults with high-risk acute lymphoblastic leukemia. The aim of this study was to analyze whether the results changed over time and to identify prognostic factors. Adult patients tr
Externí odkaz:
https://doaj.org/article/3403063ff3164851be78d34dd249aa26
Autor:
Paolo Corradini, Gerald Wulf, Christopher P. Fox, Lutz P. Müller, Nicolaus Kröger, Nadira Duraković, Michel van Gelder, Nicolaas Schaap, Jan J. Cornelissen, Peter Dreger, Mohamad Sobh, Christof Scheid, Hélène Schoemans, Paul Browne, Linda Koster, Jennifer Hoek, Mauricette Michallet, Silvia Montoto, William Krüger, Ariane Boumendil, Wolfgang Bethge, Jakob Passweg, Johannes Schetelig, Domenico Russo
Publikováno v:
Bone Marrow Transplantation, 55, 884-890
Bone Marrow Transplantation, 55(5), 884-890. Nature Publishing Group
Bone Marrow Transplantation, 55, 5, pp. 884-890
Bone Marrow Transplantation, 55(5), 884-890. Nature Publishing Group
Bone Marrow Transplantation, 55, 5, pp. 884-890
Contains fulltext : 220662.pdf (Publisher’s version ) (Closed access) The purpose of our study is to provide information on safety and efficacy of ibrutinib as salvage treatment after allo-HSCT for CLL. A total of 56 patients were included, 36 (64%
Autor:
Peter O'Gorman, Jacob P. Laubach, Michael E. O'Dwyer, Janusz Krawczyk, Andrew J. Yee, Oonagh Gilligan, Mary R. Cahill, Jacalyn Rosenblatt, John Quinn, Philip T. Murphy, Heidi DiPietro, Meegahage Ratnakanthi Perera, Gerard M. Crotty, Kristen Cummings, Patrick J. Hayden, Paul Browne, Alexandra Savell, Hilary M. O'Leary, Denis O'Keeffe, Kelly Masone, Brian J. Hennessy, Thomas Guerrero Garcia, Kathleen Scott, Khalid Saeed, Giada Bianchi, Paul Dowling, Ciara Tierney, Paul G. Richardson
Publikováno v:
American journal of hematologyREFERENCES. 97(5)
There are limited prospective data on lenalidomide, subcutaneous bortezomib, and dexamethasone (RsqVd) in transplant-eligible/transplant-ineligible patients with newly diagnosed multiple myeloma. Reliable biomarkers for efficacy and toxicity are requ
Autor:
Johannes Schetelig, Patrice Chevallier, Michel van Gelder, Jennifer Hoek, Olivier Hermine, Ronjon Chakraverty, Paul Browne, Noel Milpied, Michele Malagola, Gerard Socié, Julio Delgado, Eric Deconinck, Ghandi Damaj, Sebastian Maury, Dietrich Beelen, Stéphanie Nguyen Quoc, Paneesha Shankara, Arne Brecht, Jiri Mayer, Mathilde Hunault-Berger, Jörg Bittenbring, Catherine Thieblemont, Stéphane Lepretre, Henning Baldauf, Liesbeth C. de Wreede, Olivier Tournilhac, Ibrahim Yakoub-Agha, Nicolaus Kröger, Peter Dreger
Publikováno v:
Bone Marrow Transplantation
Bone Marrow Transplantation, Nature Publishing Group, 2021, ⟨10.1038/s41409-021-01516-2⟩
Bone Marrow Transplantation, Nature Publishing Group, 2021, ⟨10.1038/s41409-021-01516-2⟩
The Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party, written by Johannes Schetelig, Patrice Chevallier, Michel van Gelder, Je
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d3053d36d16e5addd4c395a6139a81a
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85119135810
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85119135810
Autor:
Mahmoud Aljurf, Paul Browne, Simona Iacobelli, Marie Robin, Jennifer Hoek, Péter Reményi, Nicolaus Kroeger, John A. Snowden, Ibrahim Yakoub Agha, Henrik Sengeloev, Elena V. Morozova, Henric-Jan Blok, Yves Chalandon, Arnold Ganser, Arnon Nagler, Grzegorz Helbig, Riitta Niittyvuopio, Hélène Labussière Wallet, Eduardo Olavarria, Patrick Hayden, Stavroula Masouridi-Levrat, Theo de Witte, Jakob Passweg, Gwendolyn Van Gorkom
Publikováno v:
Bone Marrow Transplantation, 57(1), 23-30. Nature Publishing Group
Masouridi-Levrat, S, Olavarria, E, Iacobelli, S, Aljurf, M, Morozova, E, Niittyvuopio, R, Sengeloev, H, Reményi, P, Helbig, G, Browne, P, Ganser, A, Nagler, A, Snowden, J A, Robin, M, Passweg, J, Van Gorkom, G, Wallet, H L, Hoek, J, Blok, H J, De Witte, T, Kroeger, N, Hayden, P, Chalandon, Y & Agha, I Y 2022, ' Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors : a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT ', Bone Marrow Transplantation, vol. 57, no. 1, pp. 23-30 . https://doi.org/10.1038/s41409-021-01472-x
Bone marrow transplantation, Vol. 57, No 1 (2022) pp. 23-30
Bone Marrow Transplantation
Bone Marrow Transplantation, 57, 1, pp. 23-30
Bone Marrow Transplantation, 57, 23-30
Masouridi-Levrat, S, Olavarria, E, Iacobelli, S, Aljurf, M, Morozova, E, Niittyvuopio, R, Sengeloev, H, Reményi, P, Helbig, G, Browne, P, Ganser, A, Nagler, A, Snowden, J A, Robin, M, Passweg, J, Van Gorkom, G, Wallet, H L, Hoek, J, Blok, H J, De Witte, T, Kroeger, N, Hayden, P, Chalandon, Y & Agha, I Y 2022, ' Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors : a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT ', Bone Marrow Transplantation, vol. 57, no. 1, pp. 23-30 . https://doi.org/10.1038/s41409-021-01472-x
Bone marrow transplantation, Vol. 57, No 1 (2022) pp. 23-30
Bone Marrow Transplantation
Bone Marrow Transplantation, 57, 1, pp. 23-30
Bone Marrow Transplantation, 57, 23-30
Contains fulltext : 248798.pdf (Publisher’s version ) (Open Access) Allogeneic hematopoietic cell transplantation (allo-HCT) remains a treatment option for patients with chronic myeloid leukemia (CML) who fail to respond to tyrosine kinase inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff78e844b861cf75faadfac5cf13700c
https://cris.maastrichtuniversity.nl/en/publications/4eab7206-4d79-4109-9ce6-4da16dcc7250
https://cris.maastrichtuniversity.nl/en/publications/4eab7206-4d79-4109-9ce6-4da16dcc7250
Autor:
Anna Waszczuk-Gajda, Olaf Penack, Giulia Sbianchi, Linda Koster, Didier Blaise, Péter Reményi, Nigel Russell, Per Ljungman, Marek Trneny, Jiri Mayer, Simona Iacobelli, Guido Kobbe, Christof Scheid, Jane Apperley, Cyrille Touzeau, Stig Lenhoff, Esa Jantunen, Achilles Anagnostopoulos, Laura Paris, Paul Browne, Catherine Thieblemont, Nicolaas Schaap, Jorge Sierra, Ibrahim Yakoub-Agha, Laurent Garderet, Jan Styczynski, Helene Schoemans, Ivan Moiseev, Rafael F. Duarte, Zinaida Peric, Silvia Montoto, Anja van Biezen, Malgorzata Mikulska, Mahmoud Aljurf, Tapani Ruutu, Nicolaus Kröger, Curly Morris, Christian Koenecke, Stefan Schoenland, Grzegorz W. Basak
Publikováno v:
Journal of Clinical Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of Clinical Medicine; Volume 11; Issue 12; Pages: 3541
Journal of Clinical Medicine, 11
Journal of Clinical Medicine, 11, 12
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of Clinical Medicine; Volume 11; Issue 12; Pages: 3541
Journal of Clinical Medicine, 11
Journal of Clinical Medicine, 11, 12
Contains fulltext : 251609.pdf (Publisher’s version ) (Open Access) BACKGROUND: The main goal of this post hoc analysis of the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study was to evaluate the rate of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e170483d86065de84f151bb5959f956
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12046
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12046
Autor:
Grzegorz W. Basak, Jiri Mayer, Soledad González Muñiz, Paul Bosman, Giulia Sbianchi, Johan Lund, Jane F. Apperley, Guido Kobbe, Stig Lenhoff, Sarah Lawless, Curly Morris, Cecilia Isaksson, Esa Jantunen, Achilles Anagnostopoulos, Paul Browne, Jennifer Byrne, Didier Blaise, Simona Iacobelli, Alessandro Rambaldi, Ibrahim Yakoub-Agha, Péter Reményi, Nicolaas Schaap, Keith M.O. Wilson, Stefan Schönland, Nicolaus Kröger, Christof Scheid, Cyrille Touzeau, Laurent Garderet
Publikováno v:
Clinical Lymphoma Myeloma & Leukemia, 21, 686-693
Clinical Lymphoma, Myeloma and Leukemia, 21(10), 686-693. CIG MEDIA GROUP, LP
Clinical Lymphoma Myeloma & Leukemia, 21, 10, pp. 686-693
Clinical Lymphoma, Myeloma and Leukemia, 21(10), 686-693. CIG MEDIA GROUP, LP
Clinical Lymphoma Myeloma & Leukemia, 21, 10, pp. 686-693
The rare myelomas, immunoglobulin (Ig)D, IgM, and non-secretory, have been associated with poorer outcomes following treatment than the common myelomas (IgG, IgA, and light-chain only). We show that even with "novel" therapies, augmented with autolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c144cc4a414ce17f2a367c91656e25de
https://hdl.handle.net/1887/3281911
https://hdl.handle.net/1887/3281911